Delivra Health Navigates Geopolitical Headwinds as E-Commerce Growth Accelerates

Why It Matters

Delivra’s ability to offset rising supply‑chain costs with strong e‑commerce growth signals resilience, making it a potentially attractive play for investors seeking exposure to health‑brand distribution amid global uncertainty.

Key Takeaways

• Geopolitical tensions raise tariffs, insurance, and logistics costs.
• E‑commerce sales rose 13% YTD, 32% YoY this year.
• Innovation pipeline and new customers fuel North American growth.
• CEO stresses controlling what’s possible while external risks persist.
• Strategic plan targets post‑conflict recovery and market expansion.

Summary

Delivra Health Brands CEO Gord Davey discussed how the company is coping with rising geopolitical tensions, especially the Middle East conflict, which have pushed up tariffs, freight and insurance costs. The conversation, part of the firm’s three‑nine‑month financial review ending March 31, highlighted the broader macro environment affecting health‑brand distributors.

Despite those headwinds, Delivra reported a 13% year‑to‑date increase in e‑commerce sales and a 32% jump compared with the same period last year. The growth is driven by new product innovations, onboarding of fresh customers, and expanding its North American footprint, which the CEO said is a segment the company can more directly control.

“We focus on what we can control,” Davey emphasized, noting that online channels allow tighter management of content, pricing and inventory. He pointed to the accelerated shift of Middle‑East consumers toward digital purchasing as a catalyst, and cited the rollout of upcoming product lines as evidence of the firm’s proactive strategy.

The outlook suggests that if geopolitical pressures ease, Delivra’s e‑commerce momentum could translate into broader profitability and market share gains. Investors and partners should watch the company’s ability to leverage its innovation pipeline and North American growth while navigating cost volatility.

Original Description

Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to discuss the company’s financial and operating results for the three and nine months ended March 31, 2026, highlighting the impact of geopolitical disruptions on international sales while emphasizing the continued strength of its core brands and growing e-commerce business.

Delivra Health’s portfolio includes the well-established Dream Water® and LivRelief™ brands, which are focused on addressing common consumer health concerns including sleep support, chronic pain management, anxiety relief, and overall wellness. Despite facing external challenges during the reporting period, management said consumer demand for the company’s products remains resilient across key markets.

Davey explained that quarterly and year-to-date revenue was primarily affected by reduced sales from the United States to the company’s distribution partners in the Middle East. Ongoing geopolitical tensions in the region, including disruptions associated with the closure of the Strait of Hormuz, significantly impacted the movement of goods and delayed shipments of Dream Water® products to distributors and retail partners. These disruptions accounted for much of the decline in sales compared with the same period in the previous year.

As a result, Delivra reported a 24% decrease in net revenue, driven largely by lower Dream Water® sales into international distribution channels. The company also faced additional pressure from rising costs for certain product ingredients, creating further short-term challenges for margins and overall financial performance.

Despite these temporary setbacks, management remains optimistic about a recovery in international sales. Davey noted that the company expects shipping and delivery activity into affected regions to resume during the fourth quarter and into fiscal 2027. Delivra has already received new order commitments and growth forecasts from international partners, providing confidence that sales volumes can return to historical levels once logistical constraints ease.

Meanwhile, the company continues to see encouraging progress in its direct-to-consumer and e-commerce operations. Dream Water® Canada generated a 13% increase in year-to-date e-commerce sales, while LivRelief™ recorded an even stronger 32% increase over the same period. Management believes these results demonstrate strong brand loyalty, increasing consumer engagement, and a growing level of repeat purchases across North America.

The company also completed the transition of its licensed LivRelief™ Infused product portfolio, a move designed to support a more efficient distribution model and improve long-term market reach. Management expects the revised channel strategy to strengthen future sales performance and enhance customer access to the product line.

Looking ahead, Delivra Health is actively working to optimize distribution channels, improve inventory flow, and capitalize on expanding e-commerce opportunities. Management believes these initiatives, combined with the anticipated normalization of international shipments, will help stabilize operations and support accelerated growth throughout fiscal 2027.

#proactiveinveestors #delivrahealthbrandsinc #tsxv #dhb #otcqb #dhbuf #DreamWater #GlobalExpansion #DreamWater #LivRelief #CBD #Cannabis #Wellness #Topicals #Canada #ConsumerGoods #LivRelief #Healthcare #CannaTech